http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150041831-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-02 |
| filingDate | 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150041831-A |
| titleOfInvention | β, dimethylacrylshikonin as an active ingredient, a cancer cell ionizing radiation sensitizing agent |
| abstract | The present invention relates to a cancer cell-ionizing radiation sensitizing agent comprising?,? - Dimethylacrylshikonin as an active ingredient, and a method for sensitizing a cancer cell against ionizing radiation using the same. The present inventors have demonstrated that?,? - Dimethylacrylshikonin sensitizes the response of cancer cells to ionizing radiation through the increase of ROS (Reactive Oxygen Species). The present invention is characterized by being a radiation sensitizing agent for cancer cells containing?,? - Dimethylacrylshikonin as an active ingredient. Further, the method is characterized in that β, β-Dimethylacrylshikonin is used to sensitize cancer cells to radiation. |
| priorityDate | 2013-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.